Age, Age-Related Comorbidities and Survival in Palbociclib, Ribociclib and Abemaciclib Users With Advanced Breast Cancer: A Nation-Wide Retrospective Cohort Study - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Impact of Age and Associated Comorbidities on Survival Outcomes in Patients with Advanced Breast Cancer Treated with Palbociclib, Ribociclib, and Abemaciclib: A Nationwide Retrospective Analysis

  • By

  • Blair Rajamaki

  • Olli Tenhunen

  • Liisa Pylkkänen

  • Thuan Vo

  • Anne Paakinaho

  • Miia Turpeinen

  • Sirpa Hartikainen

  • Anna-Maija Tolppanen

  • July 1, 2026

Share

Original Source(s)

Related Content